Press releases

Patent for the diagnostic test DiBiCol granted in Japan

InDex Pharmaceuticals today announced that the first patent concerning the diagnostic test DiBiCol has been granted in Japan. With DiBiCol, the new and unique PCR-based test, inflammatory bowel diseases can be diagnosed quickly and safely. Primarily, it is used to differentiate between ulcerative colitis...

Read more

Last patient recruited in a Phase II study of Kappaproct

InDex Pharmaceuticals today announced that the last patient has now been recruited to its clinical Phase II study of Kappaproct, for treating steroid resistant/dependent patients with ulcerative colitis of mild to moderate degree. The study is placebo-controlled, randomized and double-blind and evaluates...

Read more